Lactate Control Enhances Growth Advantage in Fed-batch Cultures of Metabolically Engineered CHO Cells with Reduced Novel Growth-inhibitory Compound Formation
Quentin Bethune1, Cameron Harrington1 and Bhanu Chandra Mulukutla2
Upstream Process Development, Pfizer Inc, One Burtt Road, Andover MA, 01810, USA
1 Contributed equally
2 Corresponding author (email: bhanuchandra.mulukutla@pfizer.com)